Literature DB >> 164412

Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

H L Lipton.   

Abstract

An unusual biphasic central nervous system disease developed in 3-week-old Swiss outbred mice after intracerebral inoculation of the DA strain of Theiler's murine encephalomyelitis virus. Nine to 20 days postinfection 86% of mice became paralyzed, and approximately one-half of these animals survived. During this period neuronal necrosis and microglial proliferation were seen in thalamus, brainstem, and spinal cord. There was an initial phase of virus growth in spinal cord followed by persistent infection at a lower concentration. Virus antigen was readily found in the cytoplasm of neurons by immunofluorescent staining early in the course of infection, whereas after 30 days there was a paucity of cells containing virus antigen which were present only in the spinal cord white matter. Between 1 and 5 months, an intense mononuclear inflammatory cell lesion evolved in the spinal cord leptomeninges and white matter, which coincided with a mild gait disturbance in some surviving mice, and patchy demyelination was found in areas of inflammation. The acute gray matter pathology would appear to be the result of direct virus lytic effect. Although the late white matter lesion culminating in demyelination probably represents a cytocidal infection similar to the situation that exists in certain picornavirus carrier culture systems, a virus-induced immunopathological process merits further study.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 164412      PMCID: PMC415190          DOI: 10.1128/iai.11.5.1147-1155.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

Review 1.  THE VIRAL CARRIER STATE IN ANIMAL CELL CULTURES.

Authors:  D L WALKER
Journal:  Prog Med Virol       Date:  1964

2.  Visna, a demyelinating transmissible disease of sheep.

Authors:  B SIGURDSSON; P PALSSON; H GRIMSSON
Journal:  J Neuropathol Exp Neurol       Date:  1957-07       Impact factor: 3.685

3.  Pathogenesis of demyelination induced by a mouse hepatitis.

Authors:  L P Weiner
Journal:  Arch Neurol       Date:  1973-05

4.  Efficient, inefficient, and abortive infection of different mammalian cells by small RNA viruses.

Authors:  C A Buck; G A Granger; M W Taylor; J J Holland
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

5.  Cell-fusing activity of visna virus particles.

Authors:  D H Harter; P W Choppin
Journal:  Virology       Date:  1967-02       Impact factor: 3.616

6.  Observations on viral demyelinating encephalomyelitis. Canine distemper.

Authors:  H Wiśniewski; C S Raine; W J Kay
Journal:  Lab Invest       Date:  1972-05       Impact factor: 5.662

7.  Host dependence of GDVII virus: complete or abortive multiplication in various cell types.

Authors:  L S Sturman; I Tamm
Journal:  J Immunol       Date:  1966-12       Impact factor: 5.422

8.  Residual pathologic changes following murine coxsackie A and B myocarditis.

Authors:  F M Wilson; Q R Miranda; J L Chason; A M Lerner
Journal:  Am J Pathol       Date:  1969-05       Impact factor: 4.307

9.  Carrier cultures of human fetal diploid cells infected with coxsackievirus type B2.

Authors:  N H Maverakis; N J Schmidt; J L Riggs; E H Lennette
Journal:  Arch Gesamte Virusforsch       Date:  1973

10.  Observations on encephalomyelitis of mice (DA strain).

Authors:  J B DANIELS; A M PAPPENHEIMER; S RICHARDSON
Journal:  J Exp Med       Date:  1952-12       Impact factor: 14.307

  10 in total
  259 in total

1.  Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination.

Authors:  D B McGavern; L Zoecklein; K M Drescher; M Rodriguez
Journal:  Exp Neurol       Date:  1999-07       Impact factor: 5.330

2.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

3.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

4.  A coding RNA sequence acts as a replication signal in cardioviruses.

Authors:  P E Lobert; N Escriou; J Ruelle; T Michiels
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis.

Authors:  D B McGavern; P D Murray; C Rivera-Quiñones; J D Schmelzer; P A Low; M Rodriguez
Journal:  Brain       Date:  2000-03       Impact factor: 13.501

6.  Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus.

Authors:  L Zhou; Y Luo; Y Wu; J Tsao; M Luo
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  The leader polypeptide of Theiler's murine encephalomyelitis virus is required for the assembly of virions in mouse L cells.

Authors:  C Badshah; M A Calenoff; K Rundell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Viral load increases in SJL/J mice persistently infected by Theiler's virus after inactivation of the beta(2)m gene.

Authors:  S Aubagnac; M Brahic; J F Bureau
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

9.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  CD28 costimulatory blockade exacerbates disease severity and accelerates epitope spreading in a virus-induced autoimmune disease.

Authors:  K L Neville; M C Dal Canto; J A Bluestone; S D Miller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.